Robert Dyrdak

1.7k total citations
16 papers, 621 citations indexed

About

Robert Dyrdak is a scholar working on Infectious Diseases, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Robert Dyrdak has authored 16 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 6 papers in Epidemiology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Robert Dyrdak's work include SARS-CoV-2 and COVID-19 Research (7 papers), Viral Infections and Immunology Research (5 papers) and Viral gastroenteritis research and epidemiology (4 papers). Robert Dyrdak is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), Viral Infections and Immunology Research (5 papers) and Viral gastroenteritis research and epidemiology (4 papers). Robert Dyrdak collaborates with scholars based in Sweden, Switzerland and United Kingdom. Robert Dyrdak's co-authors include Jan Albert, Emma B. Hodcroft, Richard A. Neher, Valentin Druelle, Olof Hertting, Aino Fianu Jonasson, Hanna Brauner, Milan Chromek, Annelie Brauner and Peter Wiklund and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and The Lancet Infectious Diseases.

In The Last Decade

Robert Dyrdak

15 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Dyrdak Sweden 13 319 174 160 111 85 16 621
Tadatsugu Imamura Japan 14 471 1.5× 401 2.3× 421 2.6× 137 1.2× 93 1.1× 22 781
Rachel Herlihy United States 14 267 0.8× 252 1.4× 124 0.8× 48 0.4× 54 0.6× 29 597
Zhijie An China 18 284 0.9× 472 2.7× 107 0.7× 147 1.3× 92 1.1× 69 898
Aimei Xia China 9 628 2.0× 135 0.8× 95 0.6× 60 0.5× 30 0.4× 16 826
Amber Haynes United States 12 601 1.9× 628 3.6× 165 1.0× 102 0.9× 44 0.5× 20 1.1k
Eric Peterson United States 10 67 0.2× 142 0.8× 117 0.7× 39 0.4× 70 0.8× 39 532
Mohammad Hossein Razizadeh Iran 11 347 1.1× 117 0.7× 36 0.2× 48 0.4× 59 0.7× 35 701
Victoria Indenbaum Israel 18 1.7k 5.4× 113 0.6× 61 0.4× 236 2.1× 153 1.8× 53 1.9k
Shiqiang Shang China 19 256 0.8× 302 1.7× 29 0.2× 51 0.5× 106 1.2× 46 883
Paola Affanni Italy 13 263 0.8× 140 0.8× 74 0.5× 31 0.3× 23 0.3× 41 465

Countries citing papers authored by Robert Dyrdak

Since Specialization
Citations

This map shows the geographic impact of Robert Dyrdak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Dyrdak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Dyrdak more than expected).

Fields of papers citing papers by Robert Dyrdak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Dyrdak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Dyrdak. The network helps show where Robert Dyrdak may publish in the future.

Co-authorship network of co-authors of Robert Dyrdak

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Dyrdak. A scholar is included among the top collaborators of Robert Dyrdak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Dyrdak. Robert Dyrdak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sheward, Daniel J., Hrishikesh Das, Allison J. Greaney, et al.. (2024). Structural basis of broad SARS-CoV-2 cross-neutralization by affinity-matured public antibodies. Cell Reports Medicine. 5(6). 101577–101577. 7 indexed citations
2.
Dyrdak, Robert, Emma B. Hodcroft, Magnus Gisslén, et al.. (2024). Early unrecognised SARS-CoV-2 introductions shaped the first pandemic wave, Sweden, 2020. Eurosurveillance. 29(41).
3.
Humbert, Marion, David Wullimann, Julia Niessl, et al.. (2023). Functional SARS-CoV-2 cross-reactive CD4 + T cells established in early childhood decline with age. Proceedings of the National Academy of Sciences. 120(12). e2220320120–e2220320120. 15 indexed citations
4.
Winqvist, Niclas, et al.. (2022). Surveillance of tick-borne encephalitis in emerging risk areas in southern Sweden: a retrospective case finding study. European Journal of Clinical Microbiology & Infectious Diseases. 42(1). 13–22. 3 indexed citations
5.
Hodcroft, Emma B., Robert Dyrdak, Cristina Andrés, et al.. (2022). Evolution, geographic spreading, and demographic distribution of Enterovirus D68. PLoS Pathogens. 18(5). e1010515–e1010515. 37 indexed citations
6.
Sheward, Daniel J., Chang-Il Kim, Roy A. Ehling, et al.. (2022). Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study. The Lancet Infectious Diseases. 22(6). 813–820. 51 indexed citations
7.
Hedberg, Pontus, John Karlsson Valik, Suzanne D. van der Werff, et al.. (2021). Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data. Thorax. 77(2). 1–10. 35 indexed citations
8.
Dyrdak, Robert, et al.. (2021). Interactions between seasonal human coronaviruses and implications for the SARS-CoV-2 pandemic: A retrospective study in Stockholm, Sweden, 2009-2020. Journal of Clinical Virology. 136. 104754–104754. 19 indexed citations
9.
Neher, Richard A., Robert Dyrdak, Valentin Druelle, Emma B. Hodcroft, & Jan Albert. (2020). Potential impact of seasonal forcing on a SARS-CoV-2 pandemic. Swiss Medical Weekly. 150(1112). w20224–w20224. 164 indexed citations
10.
Ahlqvist, Jenny, et al.. (2020). Comparative evaluation of CLIA and EIA for Quantiferon‐TB Gold Plus. Apmis. 128(4). 343–349. 13 indexed citations
11.
Midgley, Sofie, Kimberley Benschop, Robert Dyrdak, et al.. (2020). Co-circulation of multiple enterovirus D68 subclades, including a novel B3 cluster, across Europe in a season of expected low prevalence, 2019/20. Eurosurveillance. 25(2). 30 indexed citations
12.
Dyrdak, Robert, et al.. (2019). Intra- and interpatient evolution of enterovirus D68 analyzed by whole-genome deep sequencing. Virus Evolution. 5(1). vez007–vez007. 18 indexed citations
13.
Dyrdak, Robert, Berit Hammas, K. Hansson, et al.. (2016). Outbreak of enterovirus D68 of the new B3 lineage in Stockholm, Sweden, August to September 2016. Eurosurveillance. 21(46). 71 indexed citations
14.
Dyrdak, Robert, Maria Rotzén‐Östlund, Agneta Samuelson, Margareta Eriksson, & Jan Albert. (2015). Coexistence of two clades of enterovirus D68 in pediatric Swedish patients in the summer and fall of 2014. Infectious Diseases. 47(10). 734–738. 16 indexed citations
15.
Aly, Markus, Robert Dyrdak, Tobias Nordström, et al.. (2015). Rapid increase in multidrug-resistant enteric bacilli blood stream infection after prostate biopsy-A 10-year population-based cohort study. The Prostate. 75(9). 947–956. 33 indexed citations
16.
Hertting, Olof, Petra Lüthje, Hanna Brauner, et al.. (2010). Vitamin D Induction of the Human Antimicrobial Peptide Cathelicidin in the Urinary Bladder. PLoS ONE. 5(12). e15580–e15580. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026